COMPARISON BETWEEN DEFEROXAMINE AND COMBINED THERAPY WITH DEFEROXAMINE AND DEFERIPRONE IN IRON OVERLOADED THALASSEMIA PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

TAMADDONI A.; RAMEZANI M.S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2010 | Volume:12 | Issue:6 Page(s): 655-659

Download Full-Text

View:

648

Download:

290

Cites:

Information Journal Paper

Title

COMPARISON BETWEEN DEFEROXAMINE AND COMBINED THERAPY WITH DEFEROXAMINE AND DEFERIPRONE IN IRON OVERLOADED THALASSEMIA PATIENTS

Author(s)

TAMADDONI A. | RAMEZANI M.S. | Issue Writer Certificate

Keywords

THALASSEMIA MAJOR

DEFEROXAMINE

DEFERIPRONE

CHELATION THERAPY

Abstract

Background: Iron overload is the main cause of morbidity and mortality in patients with beta THALASSEMIA MAJOR.Effective and convenient iron chelation remains one of the main targets of clinical management of THALASSEMIA MAJOR. The combined treatment with DEFEROXAMINE and DEFERIPRONE could have an increased chelation efficacy and allow drug doses and toxicity to be reduced.Methods: Eighty patients with THALASSEMIA MAJOR were randomized to receive one of the treatments: DEFEROXAMINE given in combination with DEFERIPRONE and DEFEROXAMINE alone. Changes in serum ferritin and any toxicity were determined.Results: After one year, the mean serum ferritin (±SD) in DEFEROXAMINE alone group decreased from 2945 (±591) ng/ml to 2, 451 (±352) ng/ml (p<0.001). In the group treat with DEFEROXAMINE and DEFERIPRONE, a dramatical decline was noticed from 2986 (±612) ng/ml to 2, 082 (±221) ng/ml (p<0.001). A significant improvement was observed after 6 months of combination therapy. The main side-effects were skin reactions (deferoxamine alone), nausea and arthralgia (combined therapy).Conclusion: Combination therapy is a practical and effective procedure to decrease severe iron overload in patients with beta THALASSEMIA MAJOR.

Cites

EFFICACY OF DEFROXAMINE- DEFERIPRONE ON CARDIAC FUNCTION OF PATIENTS WITH MAJOR THALASSEMIA

References

No record.

Cite

APA: Copy

TAMADDONI, A., & RAMEZANI, M.S.. (2010). COMPARISON BETWEEN DEFEROXAMINE AND COMBINED THERAPY WITH DEFEROXAMINE AND DEFERIPRONE IN IRON OVERLOADED THALASSEMIA PATIENTS. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 12(6), 655-659. SID. https://sid.ir/paper/292331/en

Vancouver: Copy

TAMADDONI A., RAMEZANI M.S.. COMPARISON BETWEEN DEFEROXAMINE AND COMBINED THERAPY WITH DEFEROXAMINE AND DEFERIPRONE IN IRON OVERLOADED THALASSEMIA PATIENTS. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2010;12(6):655-659. Available from: https://sid.ir/paper/292331/en

IEEE: Copy

A. TAMADDONI, and M.S. RAMEZANI, “COMPARISON BETWEEN DEFEROXAMINE AND COMBINED THERAPY WITH DEFEROXAMINE AND DEFERIPRONE IN IRON OVERLOADED THALASSEMIA PATIENTS,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 12, no. 6, pp. 655–659, 2010, [Online]. Available: https://sid.ir/paper/292331/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops